Adaptimmune Therapeutics
ADAP
$1.19
Share price
-1.65%
Change (1 day)
-13.14%
Change (1 year)
Categories
EPS for Adaptimmune Therapeutics (ADAP)
EPS in 2023 (TTM): -$0.53
According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.53. In 2022 the company made an earnings per share (EPS) of -$1.02 a decrease over its 2021 EPS that were of -$1.02.
EPS history for Adaptimmune Therapeutics from 2016 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.53 | -47.67% |
| 2022 | -$1.02 | -0% |
| 2021 | -$1.02 | 6.25% |
| 2020 | -$0.96 | -27.27% |
| 2019 | -$1.32 | 29.41% |
| 2018 | -$1.02 | 20.09% |
| 2017 | -$0.85 | -16.73% |
| 2016 | -$1.02 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 uniQure QURE | -$3.94 | 638.20% | 🇳🇱 Netherlands |
 Novavax NVAX | -$7.19 | 1,247.12% | 🇺🇸 USA |
 Exelixis EXEL | $0.28 | -153.08% | 🇺🇸 USA |
 Enzo Biochem ENZ | -$0.94 | 76.12% | 🇺🇸 USA |